The challenge
Biotech company Neuro-Bio approached us to organise a press conference in London and secure media coverage ahead of their Series B fundraiser.
Goals were to communicate results of Neuro-Bio’s scientific study, tell the story of their Alzheimer’s drug, and create supporting branded materials.
Our approach
We created a top-tier media coverage campaign with a focus on credibility and accuracy
Working with Neuro-Bio, we spoke with leading science journalists and helped pull together a panel of experts to answer questions at a live press conference. We invited a targeted group to attend the press conference in London and managed virtual attendance of journalists worldwide.
We focused on publications suitable for building Neuro-Bio’s reputation in the business and science communities, and worked with them to create supporting materials, including a press release, a media Q&A, graphics and a company leaflet.
The results
The result was a successful conference with global coverage of highlights in the press
Securing top-tier media coverage was a key goal ahead of our Series B fundraise. Sciad’s expertise and knowledge of the science media landscape was evident, and we were extremely pleased with the outcomes of the press conference.
– Baroness Greenfield, Founder and CEO of Neuro-Bio
Our Work
Take a look at examples of our work
Need help getting media coverage?
We’d love to hear from you! Head to our contact page to start a conversation.
